Publisher: Research Institute for Gastroenterology and Liver Diseases (RIGLD)
  • Register
  • Login

Gastroenterology and Hepatology from Bed to Bench

  • Home
  • Issues
    • Current
    • Archives
  • About
    • About the Journal
    • Aims and Scope
    • Editorial Team
    • Privacy Statement
    • Contact
  • For Authors
    • Submissions
    • Author Guidelines
    • Peer Review Process
  • Indexing & Abstracting
  • Announcements
Advanced Search
  1. Home
  2. Archives
  3. Vol 10, No 3 (2017):Summer
  4. Review Article

ISSN: 2008-2258

Vol 10, No 3 (2017):Summer

Biomarkers in Inflammatory bowel diseases: Insight into diagnosis, prognosisand treatment

  • Mohsen Norouzinia
  • Vahid Chaleshi
  • Amir Houshang Mohammad Alizadeh
  • Mohammad Reza Zali

Gastroenterology and Hepatology from Bed to Bench, , , Page 155-167
https://doi.org/10.22037/ghfbb.v0i0.1163 Published 5 August 2017

  • View Article
  • Download
  • Cite
  • Statastics
  • Share

Abstract

Inflammatory bowel disease (IBD) is a chronic disease of unknown etiology which mostly involves the intestine and requires a personalized approach for treatment. IBD represents a heterogeneous group of patients with inherently variable disease courses. Hence, the heterogeneity of patient populations may delay the diagnosis, clinical practice and initiation of appropriate treatment. Use of biomarkers for diagnosis and management of IBD is still necessary. Descriptions of the immunological pathway abnormalities in IBD improve assessment to identify the patient’s disease status, and relative risk of progression to complicated disease behaviors, and this information may ultimately influence therapeutic decisions. In this study, we try to explain the role of biomarkers in early diagnosis, estimating prognosis, and target agents for correct managements of IBD’s patients. This information might be important to provide insight into emerging panels of multiple IBD biomarkers and highlighting the essential role of personalizes panel for each patient.

Keywords: Inflammatory bowel diseases, Cytokines, Biomarkers
  • PDF

How to Cite

Norouzinia, M., Chaleshi, V., Mohammad Alizadeh, A. H., & Zali, M. R. (2017). Biomarkers in Inflammatory bowel diseases: Insight into diagnosis, prognosisand treatment. Gastroenterology and Hepatology from Bed to Bench, 155-167. https://doi.org/10.22037/ghfbb.v0i0.1163
  • ACM
  • ACS
  • APA
  • ABNT
  • Chicago
  • Harvard
  • IEEE
  • MLA
  • Turabian
  • Vancouver
  • Endnote/Zotero/Mendeley (RIS)
  • BibTeX
  • Abstract Viewed: 3588 times
  • PDF Downloaded: 184 times

Download Statastics

  • Linkedin
  • Twitter
  • Facebook
  • Google Plus
  • Telegram
Open Journal Systems
Keywords
Current Issue
  • Atom logo
  • RSS2 logo
  • RSS1 logo
  • Home
  • Archives
  • Submissions
  • About the Journal
  • Editorial Team
  • Contact

GHFBB journal is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0).

Print ISSN: 2008-2258
Online ISSN: 2008-4234

Support Contact: ghfbb.journal@gmail.com

 

GHFBB is an open-access journal and does not charge fees for authors who submit their articles and for readers who access PDF files of published articles.

The template of this website is designed by Sinaweb